PUBCHEM ID | 3322 |
Molecular Weight (g/mol) | 244.379 |
Molecular Formula | C17H24O |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 0 |
IUPAC Name | heptadeca-1,9-dien-4,6-diyn-3-ol |
Canonical SMILES | C=CC(O)C#CC#CC/C=C/CCCCCCC |
PUBCHEM IUPAC INCHIKEY | UGJAEDFOKNAMQD-UHFFFAOYSA-N |
Solubility Level | 2 |
Vapour Pressure | -4.502 |
XLOGP3 AA | |
CACTVS TPSA | 26.3 |
BBB Level | 0 |
Absorption Level | 1 |
EXT PPB#Prediction | 1 |
AlogP98 | 5.68 |
EXT CYP2D6#Prediction | 1 |
Mouse Female FDA | Non-Carcinogen |
Mouse Male FDA | Multi-Carcinogen |
Rat Female FDA | Single-Carcinogen |
Rat Male FDA | Non-Carcinogen |
Ames Prediction | Non-Mutagen |
Developmental / Reproductive Toxicity | Non-Toxic |
Rat Oral LD50 | 1.47454 |
Ocular Irritancy | None |
Hepatotoxic#Prediction | 0 |
Effected Human Genes | NA |
Aerobic Biodegradability Prediction | Degradable |
Physical hazards | not classified |
Health hazards | Moderate |
Environmental hazards | not classified |
Serial No. | Cas No | Gene Symbol | Organism | Interaction | Interaction Actions | PubMed Id |
---|---|---|---|---|---|---|
1 | ||||||
2 | ||||||
3 |
Serial No. | Activity Name | Details | References (PubMed) | Other details EPA (U.S) | Clinical Trials (U.S. NIH) |
---|---|---|---|---|---|
1 | Falcarinol |